1-(2-Hydroxyethyl)piperazine → 4-(2-Hydroxyethyl)piperazine-1-carboxamide
反応式
[OH:1][CH2:2][CH2:3][N:4]1[CH2:9][CH2:8][NH:7][CH2:6][CH2:5]1.C[Si]([N:14]=[C:15]=[O:16])(C)C>C(O)(C)C>[OH:1][CH2:2][CH2:3][N:4]1[CH2:9][CH2:8][N:7]([C:15]([NH2:14])=[O:16])[CH2:6][CH2:5]1参加物
4
実験手順
To a stirred solution of 1-(2-hydroxy-ethyl)-piperazine (1.95 g, 15 mmol) in isopropanol (30 mL) at rt was added trimethylsilylisocyanate (2.8 mL, 21 mmol) and the resulting solution stirred overnight before the volatiles were removed in vacuo. The residue was partitioned between CH2Cl2 and water. The aqueous phase was concentrated in vacuo to give 4-(2-hydroxy-ethyl)-piperazine-1-carboxylic acid amide (2.3 g, 88%); 1H-NMR (300 MHz, d6-DMSO) 5.92 (2H, s), 4.40 (1H, t), 3.46-3.52 (2H, m), 3.22-3.34 (4H, m), 2.30-2.39 (6H, m); m/z (ES+) 173 [M+H]+.
後処理
- customwere removed in vacuo
- customThe residue was partitioned between CH2Cl2 and water
- concentrationThe aqueous phase was concentrated in vacuo
出典と根拠
- ORDレコード
- ord-b5821917fd8e45ed9f93ad4cebeb7dd4
- 出典データセット
- uspto-grants-2009_08
- 特許番号
- US07572794B2
反応ノート
読み込み中…